Colorado's Venture Capital Pace Splits by Sector at the Midyear Mark

A quarterly report from Innosphere tracks venture capital activity across five sectors anchoring the Colorado innovation economy — Aerospace & Defense, Quantum & Photonics, Clean Tech & Climate Tech, Life Sciences, and Software-as-a-Service. It's the first release in what will be an ongoing quarterly series, building on the regional benchmarking Innosphere published earlier this month in its 2025 Venture Capital Comparison Report. Where that report measured Colorado against peer regions, this one looks inward, tracking how capital is moving sector by sector as 2026 unfolds.

The Midyear Picture

Through the first half of 2026, the five sampled industries deployed $1.69 billion in venture capital, approximately 29.56% of full-year 2025 investment, far short of the 50% pace that would put the state on track to match last year's total. However, that rollup number obscures a market moving in different directions depending on the sector. Some industries are already ahead of last year's pace, while others are moving at a fraction of their previous momentum.

Aerospace & Defense: Outpacing 2025 Already

Aerospace & Defense has deployed 88.06% of its full 2025 capital in just the first six months of 2026, the strongest pace of any sector tracked. In Q2 2026 alone, the sector logged 5 deals and $45 million in capital, with a median deal size of $22.5 million, led by Lunar Outpost's $30 million Series B and Citra Space's $15 million Series A. That momentum follows an outsized Q1, driven by True Anomaly's $650 million Series D and Agile Space Industries' $21.55 million Series A. Colorado isn’t alone in this growth. National defense tech dealmaking set a record in Q1 2026, with $19.8 billion deployed across 262 deals. Indexed to their own early-2025 baselines, Colorado’s growth trajectory and the national trajectory land closer together than in any other sector Innosphere tracks. Investors appear to be underwriting government demand signals as much as commercial traction — a distinction worth watching as the sector continues to matures.

Quantum & Photonics: Lagging Behind

On the other end of the spectrum, Quantum & Photonics is pacing furthest behind, at just 3.59% of FY 2025's total at midyear. Q2 2026 recorded only 1 deal totaling $25 million. The sector’s deal cadence is sparse by nature, with capital arriving in concentrated bursts rather than a steady flow. Q4 2025 alone was carried by Quantinuum's $838.85 million Series B, a single round that dwarfs anything since. This volatility isn’t unique to Colorado. Nationally, quantum funding hit a record $3.9 billion across 127 deals in 2025, with rounds above $100 million accounting for the overwhelming majority of capital invested, despite being a small fraction of total deal count.  

Clean Tech & Climate Tech: Steady, But Shifting Later

Clean Tech & Climate Tech sits at 44.64% of its FY 2025 pace, with Q2 2026 producing 15 deals and $132.1 million in capital. Later-stage VC accounted for half of those deals, led by AMP Sortation's $52.5 million round. The pattern points to investors favoring deployment-ready companies with proven unit economics over earlier, less-proven technology. While the sector is slightly behind its FY 2025, on a rate-of-growth basis, Colorado is outperforming the national market. Measured against its own H1 2025 starting point, Colorado’s Clean Tech & Climate Tech capital deployment has grown more than three times the national growth rate over the same period of time.

Life Sciences: Ahead of the Curve

Life Sciences is tracking above its 2025 pace, at 72.14%, driven by growth in the accelerator and early-stage pipeline beneath the sector's headline later-stage rounds. Q2 2026 recorded 6 deals and $6.47 million in capital deployed, led by Commense Bio’s $2.47 million round. Nationally, Life Science funding is having its strongest H1 since 2022 at roughly $9.1 billion in invested capital, but two-thirds of that capital is flowing to de-risked, later stage bets with drug candidates in human trials. On the other hand, Colorado has maintained a more diverse composition of investment towards accelerator and early-stage bets, and its own indexed growth rate continues to run ahead of the national growth rate.  

SaaS: Broadening, Even as It Slows

Software-as-a-Service remains Colorado's largest destination for capital, even while pacing behind 2025 at 10.69%. Q2 2026 logged 23 deals — more than any other sector — totaling $163.05 million, led by EarlyTrade's $30.93 million Series A and Notable Systems' $21.03 million Series B. Nationally, AI-native enterprise spending surged 94% year-over-year in early 2026, and the national SaaS industry has outpaced its FY 2025 at 179.6%. While Colorado lags behind at the midyear, the region didn’t produce an AI-native mega-round in H1 2026 which has commonly distorted total quarterly capital investment in the region, and the industry has continued to maintain a healthy deal volume in the absence of a mega-round.

What This Means Going Forward

Read together, these five sectors tell a more nuanced story than the topline 29.56% figure suggests. Aerospace & Defense and Life Sciences are outperforming; Quantum & Photonics, Clean Tech, and SaaS are pacing behind — for reasons ranging from deal lumpiness to a genuine shift toward later-stage, lower-risk capital. Discover more information about Colorado’s momentum in the Q2 Venture Capital Report (insert hyperlink). In order to better understand how these industries are evolving, Innosphere will continue to track how each of these sectors moves as the year progresses, with the next update following at the close of Q3 2026.

Download the PDF of the report here.

Data source: PitchBook Inc., July 2026. Deals may be ongoing, and figures are subject to change.